Form 4 Filing for Anderson J. Kermit

This Form 4 filing details a stock option grant to Anderson J. Kermit, a director at ADIAL PHARMACEUTICALS, INC. The option, for 9,185 shares of Common Stock, was granted on April 7, 2026, with an exercise price of $1.64 per share and an expiration date of April 6, 2036. The option vests in full on the earlier of the one-year anniversary of the grant date or a Change of Control, provided Mr. Kermit remains in service to the Issuer. Following the transaction, Mr. Kermit holds 9,185 shares underlying this option.